Thomas Stankovich - 30 Nov 2023 Form 4 Insider Report for ReShape Lifesciences Inc. (RSLS)

Reporting relationship: Chief Financial Officer
Issuer ticker: RSLS
Reported as of: 30 Nov 2023
Net transaction value: -$38.78
SEC form: 4
Accepted by SEC: 13 Aug 2024, 16:29:13 UTC
Prior SEC filing: 08 Nov 2023
Source filing: View source filing
Reporting owner signature: /s/ Thomas Stankovich

Key filing fact

Thomas Stankovich filed Form 4 for ReShape Lifesciences Inc. (RSLS) on 13 Aug 2024.

Key facts

This page summarizes Thomas Stankovich's Form 4 filing for ReShape Lifesciences Inc. (RSLS).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 13 Aug 2024, 16:29.

Change

Previous filing in this sequence was filed on 08 Nov 2023.
Current net transaction value: -$38.78.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RSLS transaction

Common Stock, $0.001 par value per share

Sale

Transaction value: $8.97
Shares: -39
Change %: -0.17%
Price: $0.2300
Shares after: 22,910
Date: 30 Nov 2023
Ownership: Direct
Footnotes: F1

RSLS transaction

Common Stock, $0.001 par value per share

Sale

Transaction value: $10.5
Shares: -42
Change %: -0.18%
Price: $0.2500
Shares after: 22,868
Date: 31 Dec 2023
Ownership: Direct
Footnotes: F1

RSLS transaction

Common Stock, $0.001 par value per share

Sale

Transaction value: $7.31
Shares: -43
Change %: -0.19%
Price: $0.1700
Shares after: 22,825
Date: 29 Feb 2024
Ownership: Direct
Footnotes: F1

RSLS transaction

Common Stock, $0.001 par value per share

Sale

Transaction value: $12
Shares: -48
Change %: -0.21%
Price: $0.2500
Shares after: 22,777
Date: 31 May 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On July 22, 2021, Mr. Stankovich was awarded an aggregate of 7,455 restricted stock units, all of which, including the unvested portion, were reported on a Form 4 filed on September 17, 2021. The shares reported under this Form 4 as being disposed of were sold to cover taxes in connection with the vesting of a portion of those previously reported restricted stock units.